Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment.

ABSTRACT:

SUBMITTER: Lasagna A 

PROVIDER: S-EPMC9341169 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature